TY  - GEN
AU  - Khouri,I F
AU  - Sui,D
AU  - Jabbour,E J
AU  - Samuels,B I
AU  - Turturro,F
AU  - Alatrash,G
AU  - Anderlini,P
AU  - Ahmed,S
AU  - Oran,B
AU  - Ciurea,S O
AU  - Marin,D
AU  - Olson,A
AU  - Patel,K K
AU  - Popat,U R
AU  - Ledesma,C
AU  - Kadia,T M
AU  - Ferrajoli,A
AU  - Burger,J A
AU  - Jorgensen,J L
AU  - Medeiros,L J
AU  - Bassett,R L
AU  - Gulbis,A M
TI  - Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL
SN  - 1476-5365
PY  - 2017///1214
KW  - Adult
KW  - Aged
KW  - Bendamustine Hydrochloride
KW  - administration & dosage
KW  - Cyclophosphamide
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - mortality
KW  - Male
KW  - Middle Aged
KW  - Rituximab
KW  - Survival Rate
KW  - Transplantation Conditioning
KW  - methods
KW  - Vidarabine
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1038/bmt.2016.204
ER  -